December 29, 2020Winter Garden, FL More catching up —The FDA approved another specialty therapy earlier this month. The new approval is Margenza (margetuximab-cmkb) from MacroGenics and
There really hasn’t been a lot of good news in the specialty pharmacy industry this year. Demand has been down due to the virus. Increasing
This year saw few specialty pharmacy acquisitions…. but that just changed with the announcement by Centene Corporation that it has acquired PantherRx Rare Pharmacy. Terms
Someone must have lit a fire under the FDA new drug approval elves in the last few weeks as the activity level there suddenly boomed.
We ran across a press release recently that looked a tad odd. It appeared that the FDA had approved a new therapy, Alkindi Sprinkle from
Earlier this month the FDA approved yet another orphan drug, Orladeyo (berotralstat) from BioCryst Pharmaceuticals. It obtained an indication for the prevention of hereditary angioedema
Ok, we know you are ready for more catch up….. and it ain’t the red stuff. The FDA recently approved yet another expensive specialty pharmacy
Ok, catch up time.Looking back a couple of weeks….. the FDA approved yet another rare/orphan therapy (which is mostly all they they’ve approved in 2020!).
With the emergence of CV-19 just about every health care provider has been scrambling to do something to preserve their patient relationships. A patient that
The FDA recently revved up its approval engine waving yet another specialty pharmacy checkered flag for Zokinvy (lonafarnib) from Eiger BioPharmaceuticals. Zokinvy is indicated for
